TABLE 3.
Reported Least Preferred Biosimilar Naming Convention by Employment Type
| Employment Type | Nonproprietary Only % (n) | Nonproprietary Plus Suffix % (n) | Nonproprietary Plus Prefix % (n) | Unique Brand Name % (n) |
|---|---|---|---|---|
| Hospital (n = 116) | 37.6 (44) | 4.3 (5) | 20.5 (24) | 36.8 (43) |
| Outpatient pharmaciesa (n = 122) | 20.3 (25) | 15.5 (19) | 26.0 (32) | 37.4 (46) |
| Specialty pharmacy (n = 26) | 26.9 (7) | 19.2 (5) | 26.9 (7) | 26.9 (7) |
| MCOs (n = 233) | 18.0 (42) | 4.3 (10) | 30.5 (71) | 46.8 (109) |
| Manufacturer (n = 78) | 39.7 (31) | 7.7 (6) | 25.6 (20) | 25.6 (20) |
| Academia (n = 37) | 23.7 (9) | 10.5 (4) | 5.2 (2) | 60.5 (23) |
| Other/unreported (n = 139) | 19.5 (32) | 5.5 (9) | 23.3 (38) | 36.0 (59) |
| Total | 25.4 (190) | 7.7 (58) | 25.9 (194) | 40.9 (307) |
a Includes those reporting independent, small chain, large chain, clinic nondispensing, and clinic dispensing.
MCO = managed care organization.